medigraphic.com

2005, Number S3

<< Back Next >>

Arch Cardiol Mex 2005; 75 (S3)

Primary Acute Myocarditis. A 10- years institutional experience

Guillén OF, Soto ME, Reyes PA

Language: Spanish
References: 29
Page: 81-88
PDF size: 80.46 Kb.


ABSTRACT

Acute myocarditis (AM) is associated with viral infections: Coxsackie and ECHOviruses among others. Autoimmunity has been proposed as a pathogenic mechanism. Benefit of classic immunosuppression (prednisone-azathioprine) or immunomodulation (monomeric-human IgG) is still uncertain. Objective: To review incidence and clinical approach to AM at a Cardiology referral center. Material and methods: A 10-yeard period (1992-2003) is reviewed. A standard questionary was applied to 49 consecutive patients referred by clinicians with a diagnosis of AM. Results: AM was found in 17 women and 32 men, median age 24 and 28 years, respectively. They presented heart failure with dyspnea/ortopnea (70-47%), peripheral edema/jugular vein plethora (41-37%), chest pain, and tachycardia (50%), NYHA functional class was III-IV in 22. The EKG showed sinus tachycardia or conduction defects. Transthoracic echocardiograms in 47 cases showed EF (mean) of 41% with enlarged left ventricle diameter. Antivirus antibodies were present in 54% of those cases studied, Coxsackie or ECHOvirus were identified through a serologic assay. Twenty-nine (61%) of our cases developed dilated cardiomyopathy, three patients died. It is not possible to reach a conclusion regard to immunomodulation therapy, because it was applied to only 12 patients. Conclusions: At the Instituto Nacional de Cardiología “I. Chávez”, AM depicts an incidence of 1/1,000 patients a year. It is necessary to standardize the clinical approach for diagnosis and treatment, progression to dilated cardiomyopathy and death during acute stage occurs in two-thirds of our patients.


REFERENCES

  1. Gore I, Saphir O: Myocarditis: a classification of 1,402 cases. Am Heart J 1947; 34: 827-830.

  2. Fenoglio JJ, Ursell PC, Kellogg CF, Drusin RE, Weiss MB: Diagnosis and classification of Myocarditis by endomyocardial biopsy. N Engl J Med 1983; 308: 12-18.

  3. Feldman AM, McNamara D: Myocarditis. N Engl J Med 2000; 19: 1388-1398.

  4. Wynne J, Braunwald E: Myocarditis. En Braunwald E, Zipes DP, Libby P, eds. Heart disease: A Textbook of Cardiovascular Medicine. Philadelphia: Saunders; 2001: 1784-1787.

  5. Aranda A, Cruz D: Cardiomiopatía dilatada y su relación con la miocarditis viral. Miocarditis, miocardiopatía dilatada e insuficiencia cardíaca. Soc Mex Cardiol México, D.F., Editorial Piensa S.A., 1992: 3-9.

  6. Zamora C, Pico F, Pichel D, Aranda A, Delgado L: Cardiomiopatía dilatada en niños. Estudio de 45 pacientes. Miocarditis, miocardiopatía dilatada e insuficiencia cardíaca. Soc Mex Cardiol México, D.F., Editorial Piensa S.A. 1992: 37-43.

  7. Liu P, Mason J: Advances in the understanding of myocarditis. Circulation 2001; 104: 1076-1082.

  8. Kawai C: From myocarditis to cardiomyopathy; mechanisms of inflammation and cell death. Learning from the past for the future. Circulation 1999; 99: 1091-1100.

  9. Bowles N, Richardson P, Archard L: Detection of Coxsackie B virus specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1986; 8490: 1120-1122.

  10. Archard LC, Bowles NE, Anningham L, Frecke CA, Olsen EG, Rose M, et al: Molecular probes for detection of persisting enterovirus infection of human heart and their prognostic value. Eur Heart J 1991; 12(Suppl D): 56-9.

  11. Schwaiger A, Umlauft F, Weyrer K, Larcher C, Lyons J, Muhlberger V, et al: Detection of enteroviral ribonucleic acid in myocardial biopsies from patients with idiopathic dilated cardiomyopathy by polymerase chain reaction. Am Heart J 1993; 126(2): 406-410.

  12. Jin O, Sole MJ, Butany JW, Chia K, McLaughlin PR, Liu P, et al: Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. Circulation 1990; 82: 8-16.

  13. Petronio AS, Manes MT, Di Meco F, Nardini V, Pecori F, Ceccherini-Nellis L, et al: Etiopathogenesis of dilated cardiomyopathies. Cardiologia 1993; 38(12 Suppl 1): 267-276.

  14. Grasso M, Arbustini E, Silini E, Diegoli M, Percivalle E, Ratti G, et al: Search for Coxsackievirus B3 RNA in idiopathic dilated cardiomyopathy using gene amplification by polymerase chain reaction. Am J Cardiol 1992; 69(6): 658-664.

  15. McManus BM, Yanagawa B, Rezai N, Luo H, Taylor L, Zhang M, et al: Genetic determinants of Coxsackievirus B3 pathogenesis. Ann N Y Acad Sci 2002; 975: 169-79.

  16. Parrillo J: Inflammatory cardiomyopathy (myocarditis) Which patients should be trart with anti-inflammatory therapy? Circulation 2001; 104: 4-6.

  17. Menciga S, Tamariz-Martel A, Riaza-Gómez M, Molina J: Miocarditis aguda ¿Un diagnóstico olvidado en las urgencias pediátricas? An Esp Pediatr 1999; 50: 295-298.

  18. Orinius E: The late cardiac prognosis after Coxsackie B infection. Acta Med Scand 1968; 183: 235-7.

  19. O´Connell J, Henkin R, Robinson J, Subramanian R, Path, Scanlon P, et al: Gallium-67 imaging in patients with dilated cardiomyopathy and biopsy-proven myocarditis. Circulation 1984; 70: 58-62.

  20. William G, Palacios I, Yasuda T: Antimiosin antibody cardiac imaging: its role in the diagnosis of myocarditidis. J Am Coll Cardiol 1990; 16: 97-104.

  21. Narula J, Khaw BA, Dec GW, Palacios IF, Newell J, Southern, et al: Diagnostic accuracy of antimyosin scintigraphy in suspected myocarditis. J Nucl Cardiol 1996; 5: 443-445.

  22. Matsumori A, Yamada T, Sasayama S: Antimyosin antibody imaging in clinical myocarditis and cardiomyopathy: principle and application. Int J Cardiol 1996; 54: 183-190.

  23. Aretz HT: Myocarditis: The Dallas criteria. Hum Path 1987; 18: 619-24.

  24. Mason JW, O´Connell JB, Herskowitz A: A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 1995; 333: 269-275.

  25. Almazán A, Murillo H, Badui E: Utilidad de la biopsia endomiocárdica en miocarditis y cardiomiopatía dilatada. Arch Inst Cardiol Mex 1989; 59: 573-577.

  26. Rezkalla SH, Raikar S, Kloner RA: Treatment of viral myocarditis with focus on captopril. Am J Cardiol 1996; 77: 634-637.

  27. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Glanowska G, Wilczewski P, Niklewski T, et al: Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year-follow-up results. Circulation 2001; 104: 39-45.

  28. Drucker N, Colan S, Lewis A, Beiser A, Wessel D, Takahashi M, et al: g-Globulin treatment of acute myocarditis in the pediatric population. Circulation 1994; 89: 252-257.

  29. McNamara D, Holubkov R, Starling RC, Dec GW, Loh E, Torre-Amione G, et al: Intervention in myocarditis and acute cardiomyopathy with immune globulin: results from the randomized placebo controlled IMAC Trial. Circulation 1999; 100: 1-21.




2020     |     www.medigraphic.com